Cameron Horner: Whole Blood in Prehospital Care – What Does the Best Evidence Tell Us?
Cameron Horner, Clinical Advisor and Clinical Audit Manager at HEMS Clinical NZ, shared a post on LinkedIn:
“Whole blood in the prehospital environment: promising concept, but what does the best trial tell us?
The SWiFT trial included 942 patients with life-threatening traumatic haemorrhage, comparing up to two units of prehospital whole blood with standard component therapy.
The headline result: no improvement in mortality or massive transfusion. The primary outcome occurred in 48.7% of the whole-blood group and 47.7% of the standard-care group.
That doesn’t mean whole blood has no place in prehospital critical care. It means a compelling physiological rationale hasn’t automatically translated into better outcomes in this trial.
There are important caveats: only 616 patients were included in the primary analysis, the dose was limited to two units, and pragmatic prehospital care involves variation in patient selection, logistics and delivery.
For CCPs, the takeaway isn’t to abandon innovation. It’s to stay honest about uncertainty, understand the system around the intervention, and keep asking whether it changes outcomes for the patients we serve — from rural communities to urban trauma scenes.
The best care is not always the newest intervention. It’s the right intervention, for the right patient, at the right time.”
Stay updated with Hemostasis Today.
-
Nov 12, 2026, 22:35Carmen’s Recovery From Spontaneous Coronary Artery Dissection – American Heart Association
-
Nov 12, 2026, 22:34What’s Next in Comprehensive Care for Hemophilia and Other Bleeding Disorders? – WFH
-
Nov 12, 2026, 22:33Sanjay Ahuja: Presenting on Artificial Intelligence in Hematology Learning and Practice at ASH 2026
-
Nov 12, 2026, 16:35Mohamed Hesham Gamal: Intravenous Thrombolysis Shows Strong Safety Profile in Stroke Mimics
-
Nov 12, 2026, 14:35Mokhtar Tazik: Connecting Clinical Demand with Plasma Collection and Fractionation Capacity
-
Nov 12, 2026, 14:25Kim Phelan: Celebrating Dr. Marilyn Manco-Johnson as a Recipient of the 2026 Eternal Spirit Award
-
Nov 12, 2026, 14:20Shailesh Kucha: Ensuring Transfusion Safety Through Biochemical Assessment of Stored Red Cells
-
Nov 12, 2026, 14:20Akshat Jain: Wonderful Time Presenting at the ATHN 2026
-
Nov 12, 2026, 14:08Elisa Gabinaud: The Evolving Science of Megakaryocyte Development